Gene: ARK2N
Official Full Name: arkadia (RNF111) N-terminal like PKA signaling regulator 2Nprovided by HGNC
Gene Summary: Enables transcription corepressor activity. Involved in negative regulation of viral life cycle. Is active in chromatin. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO19687 | ARK2N Knockout cell line (HeLa) | Human | ARK2N | 1:3~1:6 | Negative | Online Inquiry |
KO19688 | ARK2N Knockout cell line (HCT 116) | Human | ARK2N | 1:2~1:4 | Negative | Online Inquiry |
KO19689 | ARK2N Knockout cell line (HEK293) | Human | ARK2N | 1:3~1:6 | Negative | Online Inquiry |
KO19690 | ARK2N Knockout cell line (A549) | Human | ARK2N | 1:3~1:4 | Negative | Online Inquiry |
ARK2N Gene Knockout Cell Lines represent an advanced biological tool designed for researchers aiming to explore gene function and regulatory mechanisms at a cellular level. These engineered cell lines have been meticulously developed through homologous recombination techniques to silence ARK2N expression, thus providing a powerful model to investigate the implications of this specific gene in various biological processes, including cellular signaling, differentiation, and disease pathology.
The primary function of ARK2N Gene Knockout Cell Lines lies in their ability to facilitate in-depth studies of ARK2N's role in cellular behavior. By employing CRISPR-Cas9 technology, the knockout process guarantees precise gene disruption, enabling researchers to delineate the consequences of ARK2N loss of function. This technique also opens avenues to explore compensatory mechanisms and pathway interactions, thereby enhancing the understanding of genetic networks within cells.
In the realm of scientific research and clinical applications, these cell lines are invaluable for drug discovery, biomarker identification, and understanding disease mechanisms, particularly in cancer and neurodegenerative conditions. Their role in elucidating gene expression profiles can significantly aid in the development of targeted therapies, allowing clinicians to tailor treatments based on genetic modifications.
ARK2N Gene Knockout Cell Lines offer several advantages over traditional methods, such as stable shRNA or siRNA approaches, by providing a permanent genetic alteration without the risk of transient gene silencing. This quality ensures consistent and reproducible experimental outcomes across multiple studies, thereby increasing the reliability of results.
For researchers, clinicians, and pharmaceutical developers, the value of ARK2N Gene Knockout Cell Lines is underscored by their potential to accelerate the pace of discovery and innovation in genetics and molecular biology. At [Your Company Name], we pride ourselves on creating high-quality, well-characterized biological products that empower scientific advancement and help address critical questions in health and disease. Our expertise in cell line engineering and genetic manipulation ensures that our products not only meet but exceed the expectations of the research community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.